BioCentury | Aug 11, 2020
Product Development

Phase II learnings set up microbiome play Seres for Phase III success

...Orphan drug designations.Competitors aren’t too far behind, however.  In May, the Rebiotix Inc. unit of Ferring Pharmaceuticals Inc....
BioCentury | Jun 19, 2020
Product Development

Finch’s microbiome therapy clears bar in pivotal C. diff readout

...non-oral product has read out in a Phase III trial. In May, Rebiotix Inc. and Ferring Pharmaceuticals Inc....
BioCentury | Jun 6, 2020
Management Tracks

COVID-19 vaccine partners Lonza and Moderna announce new execs; plus Samumed, EpicentRx, Immatics, Aligos, ImmunoGen, Ferring, Sanifit and more

...CBO of the antibody-drug conjugate company last year to become president and CEO of TrisaQ. Ferring Pharmaceuticals Inc....
...Ottinger was VP, general counsel and chief administrative officer of MicroPort Orthopedics Inc. Robin Sawka, BioCentury Staff Ferring Pharmaceuticals Inc. Samumed...
BioCentury | May 8, 2020
Product Development

May 7 Quick Takes: Gaboxadol meets in Phase II for Fragile X; plus Innovent, Lilly, Tetraphase and more

...Data in Heart Failure” ). Preliminary findings for Phase III CDI trial Rebiotix Inc. and Ferring Pharmaceuticals Inc....
...Pharmaceuticals Inc. La Jolla Pharmaceutical Co. Ovid Therapeutics Inc. Innovent Biologics Inc. Eli Lilly and Co. Censa Pharmaceuticals Inc. [MERGED] AstraZeneca plc Ferring Pharmaceuticals Inc. Rebiotix...
BioCentury | Jun 28, 2010
Company News

Ferring sales and marketing update

...Ferring's Ferring Pharmaceuticals Inc. subsidiary launched its Lysteda tranexamic acid tablets in the U.S. to treat menorrhagia. The...
BioCentury | Apr 5, 2010
Company News

Ferring, Xanodyne Pharmaceuticals sales and marketing update

...Ferring's Ferring Pharmaceuticals Inc. subsidiary and Xanodyne will co-promote Xanodyne's Zipsor diclofenac in the U.S. starting May 3...
BioCentury | Jun 3, 2002
Company News

Arena, Ferring Group deal

...ARNA will use its Constitutively Activated Receptor Technology (CART) to develop for Ferring's Ferring Pharmaceuticals Inc. subsidiary an...
Items per page:
1 - 7 of 7
BioCentury | Aug 11, 2020
Product Development

Phase II learnings set up microbiome play Seres for Phase III success

...Orphan drug designations.Competitors aren’t too far behind, however.  In May, the Rebiotix Inc. unit of Ferring Pharmaceuticals Inc....
BioCentury | Jun 19, 2020
Product Development

Finch’s microbiome therapy clears bar in pivotal C. diff readout

...non-oral product has read out in a Phase III trial. In May, Rebiotix Inc. and Ferring Pharmaceuticals Inc....
BioCentury | Jun 6, 2020
Management Tracks

COVID-19 vaccine partners Lonza and Moderna announce new execs; plus Samumed, EpicentRx, Immatics, Aligos, ImmunoGen, Ferring, Sanifit and more

...CBO of the antibody-drug conjugate company last year to become president and CEO of TrisaQ. Ferring Pharmaceuticals Inc....
...Ottinger was VP, general counsel and chief administrative officer of MicroPort Orthopedics Inc. Robin Sawka, BioCentury Staff Ferring Pharmaceuticals Inc. Samumed...
BioCentury | May 8, 2020
Product Development

May 7 Quick Takes: Gaboxadol meets in Phase II for Fragile X; plus Innovent, Lilly, Tetraphase and more

...Data in Heart Failure” ). Preliminary findings for Phase III CDI trial Rebiotix Inc. and Ferring Pharmaceuticals Inc....
...Pharmaceuticals Inc. La Jolla Pharmaceutical Co. Ovid Therapeutics Inc. Innovent Biologics Inc. Eli Lilly and Co. Censa Pharmaceuticals Inc. [MERGED] AstraZeneca plc Ferring Pharmaceuticals Inc. Rebiotix...
BioCentury | Jun 28, 2010
Company News

Ferring sales and marketing update

...Ferring's Ferring Pharmaceuticals Inc. subsidiary launched its Lysteda tranexamic acid tablets in the U.S. to treat menorrhagia. The...
BioCentury | Apr 5, 2010
Company News

Ferring, Xanodyne Pharmaceuticals sales and marketing update

...Ferring's Ferring Pharmaceuticals Inc. subsidiary and Xanodyne will co-promote Xanodyne's Zipsor diclofenac in the U.S. starting May 3...
BioCentury | Jun 3, 2002
Company News

Arena, Ferring Group deal

...ARNA will use its Constitutively Activated Receptor Technology (CART) to develop for Ferring's Ferring Pharmaceuticals Inc. subsidiary an...
Items per page:
1 - 7 of 7